Donor-Specific Antibodies-The Devil Is in the Detail.

Carter, V; Howell, W M; Shaw, J A M

Carter, V; Howell, W M; Shaw, J A M.

Affiliation

Carter V; Histocompatibility and Immunogenetics, NHS Blood and Transplant, Newcastle upon Tyne, UK.
Howell WM; Histocompatibility and Immunogenetics, NHS Blood and Transplant, Newcastle upon Tyne, UK.
Shaw JAM; Newcastle University Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, UK.

Am J Transplant ; 17(7): 1959, 2017 07.

Article in En | MEDLINE | ID: mdl-28251813

Subject(s)

Antilymphocyte Serum; Islets of Langerhans; Antibody Formation; Risk Factors; Tissue Donors

Key words

alloantibody; clinical research/practice; graft survival; immunobiology; immunogenetics; immunosuppressive regimens; islet transplantation; minimization/withdrawal; panel reactive antibody (PRA)

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Islets of Langerhans / Antilymphocyte Serum Type of study: Etiology_studies / Risk_factors_studies Language: En Journal: Am J Transplant Journal subject: TRANSPLANTE Year: 2017 Type: Article Affiliation country: United kingdom

Fulltext

XML

PubMed Links

Search on Google